LivaNova (LIVN) Operating Margin Growth (1y) (2015 - 2026)
LivaNova (LIVN) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 146.00 |
| 10 | LivaNova | 4.33 Bn | 3.81 Bn | 273.67 Mn | -270.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -270.00 |
| Mar 31, 2026 | -390.00 |
| Dec 31, 2025 | 29.00 |
| Sep 30, 2025 | 390.00 |
| Jun 30, 2025 | 276.00 |
| Mar 31, 2025 | 983.00 |
| Dec 31, 2024 | 3,988.00 |
| Sep 30, 2024 | 964.00 |
| Jun 30, 2024 | 670.00 |
| Mar 31, 2024 | 640.00 |
| Dec 31, 2023 | -3,345.00 |
| Sep 30, 2023 | 5,380.00 |
| Jun 30, 2023 | -658.00 |
| Mar 31, 2023 | -485.00 |
| Dec 31, 2022 | -409.00 |
| Sep 30, 2022 | -5,873.00 |
| Jun 30, 2022 | 2,621.00 |
| Mar 31, 2022 | 626.00 |
| Dec 31, 2021 | 10,155.00 |
| Sep 30, 2021 | 963.00 |